Total Products under this Category: 118
Last updated: November 13, 2026
Why You Can Trust G2's Software Rankings:
G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.
Highlighted products: OpenEvidence, PathAI, Viz.ai One, MR SmartSpeed, 5C Network, Deep Resolve, Qure AI, and Lunit.
Underlying data: [Grid® JSON](https://www.g2.com/categories/ai-medical-diagnostic-platforms/grids.json?focus%5B%5D=openevidence&focus%5B%5D=pathai&focus%5B%5D=viz-ai-one&focus%5B%5D=mr-smartspeed&focus%5B%5D=5c-network&focus%5B%5D=deep-resolve&focus%5B%5D=qure-ai-2022-07-05&focus%5B%5D=lunit)
52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.
Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images.
aiEndoscopic is a Swiss MedTech company specializing in integrating artificial intelligence (AI) and robotics into endoscopy to enhance the safety and efficiency of airway management procedures. Their flagship product, larynGuide, is an assistive software designed to support clinicians during tracheal intubations by providing real-time guidance, highlighting key anatomical landmarks, and offering instant feedback. This innovation aims to simplify complex procedures, reduce the skill gap for less experienced practitioners, and improve patient outcomes in critical care situations. Key Features and Functionality: - Real-Time AI Guidance: larynGuide delivers immediate, on-screen assistance during video laryngoscopy, helping clinicians navigate the airway with precision. - Anatomical Landmark Highlighting: The software identifies and emphasizes crucial anatomical structures, facilitating accurate tube placement. - Instant Performance Feedback: Clinicians receive immediate evaluations of their technique, promoting continuous learning and skill enhancement. - Compatibility with Existing Systems: Designed to integrate seamlessly with various video laryngoscopy setups and training programs, ensuring ease of adoption. Primary Value and User Solutions: aiEndoscopic's larynGuide addresses the challenges associated with tracheal intubation, a critical procedure requiring significant expertise. By providing AI-driven, real-time guidance, the software reduces the likelihood of complications, enhances procedural safety, and supports clinicians in delivering optimal patient care. This solution is particularly beneficial in high-pressure environments where time and accuracy are paramount.
Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.
Dermalyser is an AI-powered medical device software application designed to assist healthcare professionals in the early detection and diagnosis of melanoma. By analyzing dermatoscopic images of skin lesions, Dermalyser provides real-time, accurate assessments, enhancing diagnostic precision and efficiency. Its user-friendly interface integrates seamlessly with mobile devices, enabling clinicians to make informed decisions swiftly, thereby improving patient outcomes and optimizing healthcare resources.
AI Optics is revolutionizing point-of-care diagnostics by integrating advanced artificial intelligence with proprietary handheld imaging technology. Their flagship product, the Sentinel Camera, is an FDA-cleared device designed to capture high-quality digital images of the human eye, facilitating early detection of retinal diseases. Complementing this, the forthcoming Sentinel Pro aims to incorporate on-device AI screening software to identify conditions such as Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), and Glaucoma. These innovations are crafted to be user-friendly, cost-effective, and seamlessly integrable into various healthcare settings, thereby enhancing accessibility to essential eye screenings.
AIxMed is a pioneering medical technology company dedicated to transforming cancer diagnostics through its AI-powered computational cytology platform. By digitizing 3D cytology samples and extracting clinical insights rapidly, AIxMed enhances diagnostic accuracy and workflow efficiency, ultimately improving patient care in the battle against cancer. Key Features and Functionality: - AIxURO™: This flagship solution assists in bladder cancer detection by analyzing non-invasive urine cytology specimens. It accurately identifies suspicious and atypical cells using The Paris System for Reporting Urinary Cytology (TPS), providing both quantitative and qualitative data to support clinical decision-making. - Whole Slide Imaging: AIxMed's platform enables rapid digitization of cytology slides, capturing abnormal cells across multiple Z-planes to ensure comprehensive analysis. This approach reduces bottlenecks and turnaround times, allowing pathologists to review more slides in less time. - Seamless Integration: The platform interfaces with existing laboratory information systems and digital scanners, facilitating easy adoption without significant infrastructure changes. Its efficient design uses less power and digital storage compared to traditional methods, making it both cost-effective and environmentally friendly. Primary Value and User Benefits: AIxMed addresses critical challenges in cancer diagnostics by providing a non-invasive, efficient, and accurate solution for cytology analysis. For pathologists, it streamlines workflows and reduces manual labor, leading to faster and more consistent results. Healthcare providers gain confidence in diagnosis, monitoring, and treatment plans, potentially enabling earlier detection and intervention for cancers like bladder cancer. Patients benefit from comfortable sample collection methods and the possibility of earlier-stage cancer detection, which can lead to better outcomes. Additionally, payors appreciate the cost-effectiveness of the platform, as it reduces the need for invasive procedures and associated healthcare expenses. By integrating AIxMed's computational cytology platform, stakeholders across the healthcare spectrum can enhance diagnostic accuracy, improve patient care, and optimize operational efficiencies in the fight against cancer.
Andromeda Surgical is a pioneering medical technology company specializing in autonomous surgical robots, initially focusing on endourology procedures. Founded in 2023 by Nick Damiano and Kartik Tiwari in South San Francisco, California, the company aims to revolutionize minimally invasive surgery by integrating artificial intelligence and robotics to enhance surgical precision and improve patient outcomes. Key Features and Functionality: - AI-Guided Navigation: Andromeda's platform offers a spatial navigation system that provides surgeons with GPS-like guidance through human anatomy, ensuring precise and efficient surgical procedures. - User-Friendly Interface: The system features an intuitive iPad interface, streamlining the learning process for new procedures and reducing the need for extensive robotic training programs. - Continuous Software Evolution: Designed for ongoing software updates, the platform continuously improves, offering new capabilities, enhanced precision, and support for an expanding range of procedures without requiring hardware replacements. - Autonomous Surgical Tasks: Proprietary AI models enable surgeon-in-the-loop autonomous tasks, acting as a "sous surgeon" to enhance decision-making and surgical efficiency. Primary Value and Solutions: Andromeda Surgical addresses the challenges of surgical precision, efficiency, and adaptability by providing a platform that evolves with continuous software improvements. Its AI-guided navigation and user-friendly interface empower surgeons to perform complex procedures with greater accuracy and reduced learning curves. The system's autonomous capabilities aim to standardize surgical outcomes, ensuring optimal results for every patient. By integrating seamlessly with existing surgical tools and offering regular updates, Andromeda's platform enhances operational efficiency and patient care in the operating room.
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
Biometry is a health technology company that develops diagnostic tools to support patients with chronic respiratory conditions.
Bodyport offers an innovative at-home solution for monitoring heart function and fluid status, aiming to transform heart failure management through early detection and proactive care. The core of this solution is the FDA-cleared Bodyport Cardiac Scale, a non-invasive device that measures key hemodynamic biomarkers via a patient's feet during a simple step. This data is then transmitted over a cellular connection to healthcare providers within minutes, facilitating timely interventions and improved disease management. Key Features and Functionality: - Cardiac Scale: Utilizes advanced sensors and proprietary algorithms to non-invasively measure a wide range of hemodynamic metrics, providing a comprehensive view of heart function and fluid status from the comfort of home. - Congestion Index: An advanced algorithm that combines multiple hemodynamic biomarkers into a single composite metric, accurately detecting early signs of worsening heart failure. Clinical studies have shown that the Congestion Index detects 70% of heart failure events—twice as many as standard weight-based methods—while generating fewer false alerts. - Comprehensive Care Platform: Integrates a robust clinical portal with an intuitive patient app, delivering timely, actionable insights. Clinicians receive clear signals to guide care, while patients benefit from a supportive at-home experience. The platform supports seamless integration with leading Electronic Health Records (EHRs) and third-party systems, and includes features for Remote Patient Monitoring (RPM) billing and compliance tracking within a fully HIPAA-compliant, SOC 2-certified system. Primary Value and User Benefits: Bodyport's solution addresses the critical need for early detection of worsening heart failure, enabling healthcare providers to intervene proactively and prevent hospitalizations. By offering a non-invasive, easy-to-use device that integrates seamlessly into daily routines, Bodyport empowers patients to monitor their heart health effectively at home. This approach not only enhances patient engagement and self-management but also provides clinicians with accurate, timely data to tailor therapeutic actions, ultimately improving patient outcomes and reducing healthcare costs.
Boston Medical Sciences focuses on conducting research, prevention, and diagnostics procedures to eliminate colorectal cancer deaths.
Buoy Health is an AI-driven platform designed to assist individuals in understanding their health concerns and navigating to appropriate care. By engaging users in a conversational interface, Buoy's AI asks personalized questions to assess symptoms and provide tailored guidance, effectively acting as a virtual health assistant. Key Features and Functionality: - AI-Powered Symptom Checker: Buoy's advanced AI evaluates user-reported symptoms to suggest possible conditions and recommend next steps, such as self-care measures or seeking professional medical attention. - Clinically Vetted Content: The platform offers a comprehensive library of articles and resources authored and reviewed by medical professionals, ensuring users have access to accurate and reliable health information. - Developer API: Buoy provides an API that allows integration of its symptom-checking and triage engine into other websites or applications, enabling organizations to offer personalized health guidance within their own platforms. Primary Value and User Solutions: Buoy Health addresses the common challenge of self-diagnosing health issues through unreliable online searches. By offering an interactive and personalized experience, it empowers users to make informed decisions about their health, reducing uncertainty and guiding them to appropriate care. This approach not only enhances individual health literacy but also helps alleviate unnecessary visits to healthcare facilities, optimizing resource utilization within the healthcare system.
Catch Mobile Health is a comprehensive mobile application designed to empower individuals in managing their health and wellness effectively. By integrating various health-related functionalities into a single platform, it offers users a seamless experience to monitor and improve their well-being. Key Features and Functionality: - Personalized Health Tracking: Users can monitor vital health metrics such as heart rate, blood pressure, and daily activity levels, enabling them to stay informed about their health status. - Medication Reminders: The app provides timely notifications to ensure users adhere to their prescribed medication schedules, reducing the risk of missed doses. - Appointment Scheduling: Users can book and manage medical appointments directly through the app, streamlining the process of accessing healthcare services. - Health Education Resources: Catch Mobile Health offers a library of articles and videos on various health topics, empowering users with knowledge to make informed decisions. - Integration with Wearable Devices: The app syncs with popular wearable health devices, allowing for real-time data collection and analysis. Primary Value and User Benefits: Catch Mobile Health addresses the common challenges individuals face in managing their health by consolidating essential tools into one user-friendly application. It simplifies health monitoring, enhances medication adherence, and facilitates access to healthcare resources. By providing personalized insights and reminders, the app encourages proactive health management, ultimately leading to improved health outcomes and a better quality of life for its users.
Clearstep is an AI-driven healthcare platform designed to enhance patient access and streamline operational efficiencies within healthcare organizations. By integrating advanced artificial intelligence with clinically validated protocols, Clearstep empowers patients to accurately self-navigate to appropriate care services, thereby delivering on the promise of patient-centric care. Healthcare providers benefit from greater insights and efficiency through clinical AI workflow automation. Key Features and Functionality: - Smart Access Suite: Virtual Triage - Symptom Checker: This feature allows patients to check symptoms, self-triage, receive care guidance, and schedule virtual or in-person doctor appointments in minutes. - Smart Access Suite: Care Navigation - Patient Engagement Chatbot: An AI-powered chatbot that automates routine patient requests, decreases the workload of care teams, and streamlines the patient intake process. - Capacity Optimization Suite: This suite optimizes healthcare scheduling by offering AI-driven automation, real-time analytics, and configurable workflows that streamline operations without sacrificing flexibility. Primary Value and Solutions Provided: Clearstep addresses critical challenges in healthcare by improving patient access and engagement, overcoming staff shortages and burnout, and increasing operational efficiencies without escalating costs. By enabling self-service symptom checks, digital triage, and efficient scheduling, Clearstep ensures patients receive timely and appropriate care, enhancing overall satisfaction and health outcomes.
Curaberg specializes in cutting-edge AI solutions for medical diagnostics, with a focus on improving early cancer prediction.
